InnoCare Pharma Limited (HKG: 9969)

InnoCare Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 8, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,213	13,677	24,677	22,945	17,378	-
Market Cap Growth	-31.48%	-44.57%	7.55%	32.04%	-	-
Enterprise Value	8,207	5,233	15,518	16,987	13,835	-
Last Close Price	6.90	6.89	13.64	15.30	13.48	-
PE Ratio	-	-16.90	-20.11	-263.84	-28.06	-
PS Ratio	13.82	16.81	34.90	17.92	10727.94	-
PB Ratio	1.39	1.73	2.86	3.30	4.63	-
P/FCF Ratio	-10.60	-13.49	-25.35	-6892.58	-34.55	-
P/OCF Ratio	-13.88	-18.66	-44.49	111.89	-84.82	-
EV/Sales Ratio	9.78	6.43	21.95	13.27	8540.54	-
EV/EBITDA Ratio	-1.60	-7.31	-19.83	-82.77	-20.92	-
EV/EBIT Ratio	-1.47	-6.71	-18.79	-75.82	-20.84	-
EV/FCF Ratio	-9.14	-5.16	-15.94	-5102.94	-27.51	-
Debt / Equity Ratio	0.24	0.23	0.20	0.23	0.37	-1.81
Debt / FCF Ratio	-2.01	-1.80	-1.79	-481.58	-2.77	-34.67
Asset Turnover	0.08	0.07	0.07	0.17	0.00	0.00
Inventory Turnover	0.99	1.39	3.81	11.13	-	-
Quick Ratio	3.61	4.13	4.44	19.29	38.75	36.48
Current Ratio	3.84	4.21	4.50	19.49	39.18	36.68
Return on Equity (ROE)	-6.71%	-8.71%	-13.44%	-1.51%	-368.36%	-
Return on Assets (ROA)	-4.41%	-4.37%	-5.15%	-1.91%	-9.77%	-7.24%
Return on Capital (ROIC)	-4.95%	-4.91%	-5.65%	-2.02%	-10.37%	-7.70%
Earnings Yield	-5.32%	-5.08%	-4.06%	-0.35%	-2.67%	-
FCF Yield	-9.43%	-7.41%	-3.94%	-0.01%	-2.89%	-
Buyback Yield / Dilution	-4.33%	-15.46%	-8.15%	-41.20%	-321.19%	-18.13%
Total Shareholder Return	-4.33%	-15.46%	-8.15%	-41.20%	-321.19%	-18.13%

Source: S&P Capital IQ. Standard template. Financial Sources.